Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
guanxin suhe wan
- Development stage
- Preclinical
- Lead developer
- Beijing Tong Ren Tang Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Guanxin Suhe Wan is a traditional Chinese medicine (TCM) herbal compound developed by Beijing Tongrentang Technology Development. Formulated as oral pills, it is primarily indicated for cardiovascular diseases, specifically coronary heart disease and angina pectoris characterized by chest pain and a feeling of suffocation. The traditional formulation typically includes five main herbal ingredients: Styrax (Suhexiang), Santalum album (Tanxiang), Dalbergia odorifera (Jiangxiang), Borneol (Bingpian), and Aristolochia debilis (Qingmuxiang). Its pharmacological actions include dilating coronary arteries, increasing coronary blood flow, reducing myocardial oxygen consumption, and inhibiting platelet aggregation. While it is a long-established TCM product, Beijing Tongrentang Technology Development is engaged in ongoing preclinical research to further evaluate its safety and efficacy profiles, particularly its protective effects against myocardial ischemia-reperfusion injury.
- Brand names
- Guanxin Suhe Wan冠心苏合丸
- Other names
- Guanxin Suhe Pills
02
Targets
NOS2 (Nitric Oxide Synthase 2)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on guanxin suhe wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on guanxin suhe wan.